Maple Health Group, LLC
Nate Smith is a Partner at Maple Health Group, LLC, a position held since January 2017, following a role as a Biotechnology Equity Research Associate at BMO Capital Markets from November 2015 to December 2016 and at Nomura from August 2015 to November 2015. Prior experience includes an Associate role at CBPartners, which transitioned from Analyst to Senior Analyst between October 2013 and July 2015, as well as a Postdoctoral Research Assistant position at Yale University. At Yale, Nate Smith focused on evaluating early-stage discoveries' commercial viability and developing intellectual property strategies. Educationally, Nate Smith holds a Ph.D. in Neuroscience from Yale University and a BSE in Biomedical and Electrical Engineering from Duke University, where experiences included roles as a Teaching Fellow and Teaching Assistant.
This person is not in the org chart
This person is not in any teams
Maple Health Group, LLC
Headquartered in New York City, we are a boutique global strategy consulting firm, providing strategic market access and HEOR insight across all phases of an asset’s development. Our core competencies include health economic modelling, interactive payer tool development, HTA and reimbursement strategy, and value proposition development and testing. We operate via a network-based consortium model, leveraging experienced and reliable research partners across a wide variety of disciplines, seamlessly integrated via a single point of contact to our clients. Our core consultant network encompasses statisticians, health economists, country-specific market access experts, and medical writers. We maintain an extensive global network of physician and payer respondents to provide up-to-date insights on the pharmaceutical, payer, and HTA landscape in countries worldwide.